tirzepatide niacinamide weight loss injection dosage Physician-led program with GLP-1 medication in Birmingham Tirzepatide and B3 Together: Safety,

Since semaglutide is approved by the FDA for diabetes management and weight loss, insurance companies are more likely to cover it for these conditions

PlexusDx offers alternative GLP-1 options including injectable semaglutide, compounded tirzepatide (a dual GLP-1/GIP receptor agonist), and the GLP-Squared dual-compound protocol

Dose adjustment should occur after 4 weeks to 0.5 mg, 1 mg, and 1.7 mg, and the maintenance dose of 2.4 mg

Doctors may prescribe it off-label, but Zepbound is the approved option for this use

Your healthcare team can provide individualised advice balancing therapeutic benefits against tolerability

For example, certain GLP1R or GIPR genotypes may respond better to escalated dosing, while others may achieve maximal benefit at lower doses